tgoop.com/CIP_USERN/83
Create:
Last Update:
Last Update:
Novel Methods to Improve the Efficiency of Radioimmunotherapy for Non-Hodgkin Lymphoma
New paper by NIIMA and CIP USERN interest groups
Radioimmunotherapy (RIT) is a novel strategy for treating non-Hodgkin lymphoma (NHL).
Several studies have shown the promising results of using RIT in NHL, which have led to FDA approval for two RIT agents in treating low grade NHL.
In this paper, novel methods that improve the efficiency of RIT and reduce its toxicity through various mechanisms are reviewed...
To read the full paper:
https://www.tandfonline.com/doi/abs/10.1080/08830185.2019.1588266?journalCode=iiri20
#Paper
@niima_usern
@cip_usern
@usern_net
BY CIP, Cancer Immunology Project

Share with your friend now:
tgoop.com/CIP_USERN/83